Therapeutic Drug Monitoring & Drugs of Abuse assays

A pioneer in the evolution of homogeneous immunoassays, Microgenics develops, manufactures and markets next-generation immunodiagnostic tests for drugs of abuse testing, therapeutic drug monitoring, calibration and linearity verification, and controls. 

*Drugs of Abuse Assays
*Serumtox Screening
*Therapeutic Drug Monitoring
*Adulteration
*Immunosuppressuve Drug Testing

We offer 2 different technologies for the analysis of the various TDM’s. Drugs of Abuse assays and Immunosuppressive Drug assays
CEDIA® immunoassays are valued worldwide for their accuracy, precision, linear 2-point calibration, lot-to-lot dependability, and stable shelf life.
DRI® products offer liquid, ready-to-use reagents, with high analytical accuracy while eliminating time-consuming steps in reagent preparation.For more information, contact your local representative.

CEDIA Technology Making Use of...

• Highly specific monoclonal antibodies
• Recombinant technology generates a consistent, specific combination of genes (cloning)
• Genetically engineered enzyme, B-galactosidase

Delivering TDM Assays With...

• Excellent precision and accuracy
  
• Optimized performance on a wide range of analyzers
• Convenient linear 2-point calibration
• Lot-to-lot consistency